We are delighted to announce the successful completion of the 3rd Edition of the International Heart Congress, held from June 5–7, 2025, in the historic city of Rome, Italy. The congress brought together an exceptional assembly of cardiologists, cardiac surgeons, researchers, healthcare professionals, and industry experts from around the world to share the latest advancements and clinical practices in cardiology and cardiovascular medicine. The event featured a dynamic scientific program with keynote addresses, plenary sessions, case studies, and poster presentations, covering a wide spectrum of topics including heart failure, interventional cardiology, cardiovascular imaging, preventive cardiology, and emerging therapies.
This edition of the International Heart Congress was marked by high-quality scientific discussions, global collaboration, and invaluable networking opportunities. The enthusiastic participation and contributions of our delegates, speakers, and partners played a vital role in the conference’s resounding success.
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain